China Life Insurance stock
2628.HKHKSEChina Life Insurance Company Limited, Financial ServicesISIN CNE1000002L3
65Score 65 out of 100, Neutral
Price and trend
44 / 100
Price history
−14% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 17% below it.
Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 53).
The price is 33% below its 52-week high. Largest decline in 20 years: 84% (October 2007 to January 2024).
Chart figures for advanced users
- SMA 50$3.40
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$3.63
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)53
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$2.87
- The lowest closing price of the last twelve months.
- Resistance$4.51
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- China Life Insurance Company Limited belongs to the Insurance (Life) industry (China) and, with a market value of $138.72B, is the largest of 34 companies in its industry on MEQIRI.
- In fiscal 2025 it earned $23.11B (up 44.1% year on year).
- MEQIRI Score 65 out of 100 (Neutral): rank 575 of 975 in Financial Services, median 68.
Show more
- The P/E is 6.1 (Insurance (Life) median 13.4, own median of recent years 8.8).
- Our model puts fair value at $10.04, with the price 70% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Below fair valuePrice 70% below the fair value of $10.04.Valuation 100
- Modestly valuedP/E 6.1, Insurance (Life) median 13.4, own median 8.8.Valuation 100
- Earnings per share growingUp 25.2% a year since 2020.Growth 71
Weaknesses
None of our weakness checks flags anything. Crash risk is measured separately.
Its standout strengths are valuation and fundamentals, while technical analysis and momentum hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
The fundamentals are strong overall.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $7.17 and expensive above $16.73 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $13.45 (excess return model) and $6.63 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 7.3%. At 8.3% the fair value would be $8.92, at 6.3% it would be $11.72.
Valuation metrics
Half from the excess return model, half from earnings times the industry P/E (13.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2025, revenue rose 18.1% on the prior year. Revenue has grown solidly since 2006, at about 5% per year.
Margins
- Operating margin
- Net margin
In fiscal 2025: operating 30%, net 25%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out. Last 12 months: net 13%.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 1 Apr 2027in 139 days
- Last reported
- 30 Oct 2026EPS reported −1.86
Analyst estimates
Analysts have cut their 2026 earnings estimate by 17.4% since 1 Nov 2026. Falling estimates often precede bad news.
- Earnings per share
- 4.46−17.4%
- Revenue
- $88.93B−8.8%
- Earnings per share
- 4.8−11.6%
- Revenue
- $96.12B−6.4%
MEQIRI has stored the estimates since 1 Nov 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at China Life Insurance
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
975 rated companies in Financial Services
- This company
- 65
- Sector median
- 68
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Insurance (Life)
The next smaller companies by market value
- AIA Group1299.HK $103.64B74
- Manulife FinancialMFC $72.55B64
- Fubon Financial Holding2881.TW $66.14B74
- MetLifeMET $64.02B73
- AflacAFL $62.57B64
- Great-West LifecoGWO.TO $58.81B72
- Life Insurance Corporation of IndiaLICI.NS $54.32B75
- Cathay Financial Holding2882.TW $50.01B71
ETFs that hold China Life Insurance
Held by 76 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares China Large Cap UCITS ETFIQQC | 2.07% | 0.74% | €697.51M |
| UBS MSCI China Universal UCITS ETF USD disUETC | 1.67% | 0.30% | €132.6M |
| iShares Dow Jones China Offshore 50 UCITS ETF (DE)EXXU | 1.65% | 0.62% | €40.6M |
Show 5 more
| Deka MSCI China ex A Shares UCITS ETFEL46 | 1.33% | 0.65% | €73.86M |
| iShares BIC 50 UCITS ETFIQQ9 | 1.28% | 0.74% | €98.42M |
| HSBC MSCI China UCITS ETFH4ZP | 1.05% | 0.28% | €865.89M |
| Franklin EM Multi-Factor Equity UCITS ETFFLXE | 0.87% | 0.30% | €102.64M |
| Franklin FTSE China UCITS ETFFLXC | 0.85% | 0.19% | €1.43B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = HK$7.8782, $1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 8 Nov 2026, previously Strong
- Valuation signal Undervalued since 8 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.